Tapinarof, however, offers a potential solution by improving the skin barrier, reducing inflammation and relieving itch ...

Ruxolitinib cream 1.5% was safe and effective for the treatment of children and adolescents with a 35% or greater body surface areas affected by atopic dermatitis, according to a study.Ruxolitinib ...

Patients with atopic dermatitis aged 2 years and older who used tapinarof cream 1% had significant improvements in various patient-reported outcomes.